Literature DB >> 9050901

Blockage of muscle and neuronal nicotinic acetylcholine receptors by fluoxetine (Prozac).

J García-Colunga1, J N Awad, R Miledi.   

Abstract

Fluoxetine (Prozac), a widely used antidepressant, is said to exert its medicinal effects almost exclusively by blocking the serotonin uptake systems. The present study shows that both muscle and neuronal nicotinic acetylcholine receptors are blocked, in a noncompetitive and voltage-dependent way, by fluoxetine, which also increases the rate of desensitization of the nicotinic receptors. Because these receptors are very widely distributed in the both central and peripheral nervous systems, the blocking action of fluoxetine on nicotinic receptors may play an important role in its antidepressant and other therapeutical effects. Our findings will help to understand the mode of action of fluoxetine, and they may also help to develop more specific medicinal drugs.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9050901      PMCID: PMC20039          DOI: 10.1073/pnas.94.5.2041

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  37 in total

1.  Effects of defolliculation on membrane current responses of Xenopus oocytes.

Authors:  R Miledi; R M Woodward
Journal:  J Physiol       Date:  1989-09       Impact factor: 5.182

2.  Effects of antidepressants on the inward current mediated by 5-HT3 receptors in rat nodose ganglion neurones.

Authors:  P Fan
Journal:  Br J Pharmacol       Date:  1994-07       Impact factor: 8.739

3.  Recording of single gamma-aminobutyrate- and acetylcholine-activated receptor channels translated by exogenous mRNA in Xenopus oocytes.

Authors:  R Miledi; I Parker; K Sumikawa
Journal:  Proc R Soc Lond B Biol Sci       Date:  1983-07-22

4.  Improved patch-clamp techniques for high-resolution current recording from cells and cell-free membrane patches.

Authors:  O P Hamill; A Marty; E Neher; B Sakmann; F J Sigworth
Journal:  Pflugers Arch       Date:  1981-08       Impact factor: 3.657

5.  Effects of serotonergic agents on neuronal nicotinic acetylcholine receptors.

Authors:  J García-Colunga; R Miledi
Journal:  Proc Natl Acad Sci U S A       Date:  1995-03-28       Impact factor: 11.205

6.  Actions of dopamine and dopaminergic drugs on cloned serotonin receptors expressed in Xenopus oocytes.

Authors:  R M Woodward; M M Panicker; R Miledi
Journal:  Proc Natl Acad Sci U S A       Date:  1992-05-15       Impact factor: 11.205

7.  Blockage of nicotinic acetylcholine receptors by 5-hydroxytryptamine.

Authors:  F Grassi; L Polenzani; A M Mileo; C G Caratsch; F Eusebi; R Miledi
Journal:  J Neurosci Res       Date:  1993-04-01       Impact factor: 4.164

8.  Distribution of alpha 2, alpha 3, alpha 4, and beta 2 neuronal nicotinic receptor subunit mRNAs in the central nervous system: a hybridization histochemical study in the rat.

Authors:  E Wada; K Wada; J Boulter; E Deneris; S Heinemann; J Patrick; L W Swanson
Journal:  J Comp Neurol       Date:  1989-06-08       Impact factor: 3.215

9.  Serotonergic modulation of muscle acetylcholine receptors of different subunit composition.

Authors:  J García-Colunga; R Miledi
Journal:  Proc Natl Acad Sci U S A       Date:  1996-04-30       Impact factor: 11.205

10.  An electrophysiological study of 5-hydroxytryptamine receptors of neurones in the molluscan nervous system.

Authors:  H M Gerschenfeld; E Stefani
Journal:  J Physiol       Date:  1966-08       Impact factor: 5.182

View more
  22 in total

1.  Neuronal nicotinic threonine-for-leucine 247 alpha7 mutant receptors show different gating kinetics when activated by acetylcholine or by the noncompetitive agonist 5-hydroxytryptamine.

Authors:  E Palma; L Maggi; F Eusebi; R Miledi
Journal:  Proc Natl Acad Sci U S A       Date:  1997-09-02       Impact factor: 11.205

2.  The GABAergic deficit hypothesis of major depressive disorder.

Authors:  B Luscher; Q Shen; N Sahir
Journal:  Mol Psychiatry       Date:  2010-11-16       Impact factor: 15.992

Review 3.  Modulation of ligand-gated ion channels by antidepressants and antipsychotics.

Authors:  Gerhard Rammes; Rainer Rupprecht
Journal:  Mol Neurobiol       Date:  2007-04       Impact factor: 5.590

4.  The efficacy of the combination of sertraline with buspirone for smoking cessation. A randomized clinical trial in nondepressed smokers.

Authors:  Jorge Luiz Carrão; Leila Beltrami Moreira; Flávio Danni Fuchs
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2007-10       Impact factor: 5.270

Review 5.  Nicotinic receptors: allosteric transitions and therapeutic targets in the nervous system.

Authors:  Antoine Taly; Pierre-Jean Corringer; Denis Guedin; Pierre Lestage; Jean-Pierre Changeux
Journal:  Nat Rev Drug Discov       Date:  2009-09       Impact factor: 84.694

6.  Essential Contributions of Serotonin Transporter Inhibition to the Acute and Chronic Actions of Fluoxetine and Citalopram in the SERT Met172 Mouse.

Authors:  Alex G Nackenoff; Alexandra B Moussa-Tooks; Austin M McMeekin; Jeremy Veenstra-VanderWeele; Randy D Blakely
Journal:  Neuropsychopharmacology       Date:  2015-10-30       Impact factor: 7.853

7.  Inhibition of G protein-activated inwardly rectifying K+ channels by fluoxetine (Prozac).

Authors:  Toru Kobayashi; Kazuo Washiyama; Kazutaka Ikeda
Journal:  Br J Pharmacol       Date:  2003-03       Impact factor: 8.739

8.  Riluzole blocks human muscle acetylcholine receptors.

Authors:  Cristina Deflorio; Eleonora Palma; Luca Conti; Cristina Roseti; Alessia Manteca; Elena Giacomelli; Myriam Catalano; Cristina Limatola; Maurizio Inghilleri; Francesca Grassi
Journal:  J Physiol       Date:  2012-03-19       Impact factor: 5.182

Review 9.  A pharmacological analysis of mice with a targeted disruption of the serotonin transporter.

Authors:  Meredith A Fox; Anne M Andrews; Jens R Wendland; Klaus-Peter Lesch; Andrew Holmes; Dennis L Murphy
Journal:  Psychopharmacology (Berl)       Date:  2007-08-22       Impact factor: 4.530

10.  Chronic treatment with fluoxetine for more than 6 weeks decreases neurogenesis in the subventricular zone of adult mice.

Authors:  Koji Ohira; Tsuyoshi Miyakawa
Journal:  Mol Brain       Date:  2011-03-08       Impact factor: 4.041

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.